Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0L7BV
|
||||
| Former ID |
DIB004294
|
||||
| Drug Name |
Gevotroline
|
||||
| Synonyms |
Carvotroline; Carvotroline hydrochloride; Gevotroline hydrochloride; WY-47384; WY-47791; Wy-46320
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Psychotic disorders [ICD9: 290-299; ICD10:F20-F29] | Discontinued in Phase 1 | [544877] | ||
| Company |
Wyeth; Wyeth-Ayerst Pharmaceuticals Inc
|
||||
| Formula |
C19H20FN3
|
||||
| Canonical SMILES |
c12c([nH]c3c1cc(cc3)F)CCN(C2)CCc1ccncc1
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Sigma(1)-type opioid receptor | Target Info | Modulator | ||
| References | |||||